jor advantage of making a minimal lesion, which, because it is "reversible," allows bilateral procedures and changes in the site of stimulation according to the programming of active electrodes. Efficacy and side effects can be balanced by adjusting the parameters of the stimulation to individual needs. Further corrections to coincide with changes in medication and evolution of the disease, especially dyskinesia, can be addressed by changing the stimulus parameters. The main disadvantage of the technique is its price and the time-consuming sessions of parameter regulation. Two main targets are presently evaluated for DBS in parkinsonism: bilateral subthalamic and pallidal DBS. Issues regarding indications for both techniques as well as their respective complications are still not settled. 20, 26, 28, 29, 40, 51 We report our experience in six patients who underwent bilateral contemporaneous pallidal stimulation with a minimum follow-up period of 24 months.
Clinical Material and Methods
Six nondemented patients who suffered from levodoparesponsive parkinsonism with severe untreatable motor fluctuations, a mean "on/off" Hoehn and Yahr stage score of 3/4.2, and a mean duration of disease of 15 years (Table  1 ) underwent bilateral contemporaneous pallidal stimulation, which was performed by one of two authors (J.G.V. and H.F.). A seventh patient was also recruited but was dropped from the evaluation after 6 months, when clear signs of multisystem atrophy appeared with bilateral pyramidal signs, autonomic dysfunction, progressive levodopa resistance, and loss of improvement despite adjustments in the stimulation. This patient had a rather unusual form of multisystem atrophy with more than 10 years of on/off fluctuations; her scores are not analyzed in this series. The six remaining patients still receive stimulation at a minimum of 24 months.
Idiopathic levodopa-responsive parkinsonism was defined by the presence of two or more of three cardinal symptoms-tremor, rigidity, or bradykinesia plus facultative gait and balance impairment and a greater than 30% improvement in the Unified Parkinson's Disease Rating Scale 12 (UPDRS) motor score on the levodopa test after 12 hours of drug holiday. After consent had been obtained, local anesthesia was induced in the patients and surgery was performed with the patients free of drug for 12 hours. The Cosman-Roberts-Wells stereotactic frame (CRW Stereotactic System; Radionics, Inc., Ghent, Belgium) was used and target imaging was obtained using magnetic resonance (MR) imaging. The target was defined as 2 to 3 mm anterior to the midcommissural point, 5 to 6 mm inferior to the anterior commissure-posterior commissure line, and 19 to 22 mm from midline, this laterality corresponding to the superolateral aspect of the optic tract. Frontal burr holes were made bilaterally and macrostimulation was performed (Stimulator Neuro N 50; FischerLeibinger GmbH, Freiburg, Germany) (1.8 mm diameter and a 2-mm exposed tip) at 2, 50, and 200 Hz for a voltage up to 4 V. After we obtained physiological confirmation of the target and absence of side effects, a DBS quadripolar electrode (model Itrel II or 3; Medtronic PS Medical, Goleta, CA) was stereotactically inserted and secured to the skull. A provisory external battery was used for 3 to 5 days, after which general anesthesia was induced in the patient and a definitive stimulator was implanted during a second operative procedure. An implantable pulse generator (IPG) (Medtronic Itrel II [four patients) or 3 [two patients]) was located in the infraclavicular region. The Itrel 7432 Programmer (Medtronic PS Medical) was used to modify the parameters of stimulation, with a 24-hour continuous stimulation. The Itrel II units were used at 185 Hz and the Itrel 3 units at 130 Hz. The mean voltage was 3.5 V (range 2.7-4.5 V) with a mean duration of stimulation lasting 75 msec (range 60-120 msec) during a 24-hour stimulation with bipolar patterns and a large field of stimulation that almost always excluded the lower electrode because of the presence of phosphenes.
Control postoperative MR imaging was performed between implantation of the electrodes and implantation of the subcutaneous IPG to confirm proper placement of the electrodes. Follow-up evaluation was conducted at 1, 3, 6, 12, 15, 18, and 24 months without a positron emission tomography scan by using a Core Assessment Program for Intractable Transplantations 34 including UPDRS scoring, Hoehn and Yahr staging, and a 3-day patients' evaluation form. A neuropsychological evaluation 1 was performed pre-and postoperatively (at 3 months) by using a standard battery of tests including language evaluation of spontaneous speech, verbal agility, verbal fluency "M" and "animals" condition, the Boston Naming Test, spelling, automatic writing, and writing in response to dictation; an examination of constructional praxis (cube design, copy of the Rey's complex geometric figure); ideomotor praxis, gnosis (Poppelreuter's embedded figures, Famous Faces Recognition), memory and attention (digit span, Corsi block design, Rey's complex geometric figure immediate and delayed recall, mirror drawing and mirror reading), executive functions (nonverbal fluency, gestural and graphomotor [Luria's] alternating sequences, alternating coordination, antisaccades, and the Trail Making Test), Raven's progressive matrices (PM38), Purdue pegboard, and motor reaction time. The Beck Depression Scale and a French scale for abulia (Habib's scale) were also completed at the time.
The demographics of the patients are summarized in Table 1 . All had levodopa-sensitive parkinsonism with untreatable fluctuations that had biphasic and mid-dose dyskinesia, in Hoehn and Yahr stages 3 (on) to 5 (off). No patient was demented. All were on a regimen of an optimal dose of levodopa and dopamine agonists (bromocriptine); for 3 years one of them had been treated with continuous parenteral apomorphine injection (3 mg/hour). 
Results
Overall, major improvements were seen in activities of daily living (ADL) scores (approximately 60%); UPDRS motor and total off scores (Ͼ 50%), mean off time (Ͼ 50%), and dyskinesia (65%). These improvements were maintained for the entire duration of the follow-up period in four patients, even though a slight increase in all mean scores is perceptible with time (Tables 2 and 3 ). All but two patients had no perceptible motor fluctuations up to 6 months; after 6 to 9 months and as long as 18 months, two other patients experienced barely perceptible fluctuations. One patient had persistent motor fluctuations despite a mean decrease of 50% in off time. Repositioning of the electrodes during a second operation at 12 months was not followed by any additional improvement. Three patients reported difficulty in gait ignition lasting 0.5 hours/day, which was not improved by any change in stimulation parameters or addition of dispersible levodopa at this time of the day. The mean levodopa dose was not changed as a result of surgery nor were the mean intakes. The three patients with fluctuations and gait ignition failure received 1 mg pergolide three times per day (two patients at Month 15 and one at Month 12) with no significant improvement.
Overall, the mean UPDRS motor on time was not significantly improved, but the mean off time per day was reduced to one-third. The mean ADL score decreased by 60%. As seen in Table 4 , the analysis of the motor subitems of the UPDRS scores showed improvements in bradykinesia, hypertonia, gait, and tremor, with better scores than those achieved with drug therapy alone.
Dyskinesia was dramatically improved, reduced to onethird the preoperative score. Only minimal dyskinesia was seen in two patients. The patient with persistent fluctuations still kept a dyskinesia score of 3 (of 4) during a few hours within the day; no improvement was achieved by any change in parameters. Dyskinesia was slightly increased after pergolide was administered to the three patients mentioned earlier, but this was decreased by adjustments to the parameters of stimulation.
Neuropsychological worsening (Table 2) was noted only for speech fluency or dysarthria in three patients and a worsening in the Beck's score in one patient. Marginal improvements in executive functions were seen in five patients. During the adjustment of parameters of stimulation, side effects such as reversible painful hemidystonia dystonia, confusion, or a general feeling of malaise, as well as transient phosphenes were described by most patients when a high voltage or duration of stimulation was used; these were reversed by a decrease in the parameters. After 1 year, three patients presented with their most disturbing deficit, intermittent gait ignition failure, which was not treatable with changes in the parameters of stimulation.
Postoperative MR imaging revealed no hematoma in these patients. One patient presented with signs of infection over the distal portion of one IPG, characterized by fluctuation and redness exhibited 1 month postoperatively; the infection was first treated with intravenous administration of amoxicillin despite a negative culture of cerebrospinal fluid. This patient never got rid of the dyskinesias and relocation of the electrodes performed at 12 months did not improve the fluctuations. Tremor was 
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* The neuropsychological examination was made using a standardized battery of tests. 50 In this battery, results are compared with those of ageand education-matched healthy controls. For the Boston Naming Test, Rey Auditory Verbal Learning Task (RAVLT), and Raven's progressive matrices, a shortened version was used. Abbreviations: B = better; M = words beginning with M; U = unchanged; W = worse. well controlled but could not be entirely eliminated by pallidal stimulation. Some degree of akinesia and fine distal motility bradyhypokinesia could not be controlled by stimulation nor could gait ignition failure, when present.
Discussion
Bilateral pallidal DBS
4 is one surgical alternative used in patients who have levodopa-responsive parkinsonism with untreatable motor fluctuations. 3, 14, 19, 22, 24, 28, 44, 57, 58 In this study seven patients underwent contemporaneous bilateral pallidal stimulation; one patient was dropped from the study for erroneous diagnosis of multiple system atrophy and data obtained in that case were not analyzed. In the remaining six cases there was follow up lasting at least 24 months. This follow up shows that the procedure is efficient, with more than a 50% decrease in ADL and motor off scores of the UPDRS scale. No significant improvement in mean motor on score could be found. When analyzing subitems of the motor scores, bradykinesia, rigidity, gait, and tremor were all improved. Relatively drug-resistant symptoms such as akinesia, especially gait ignition failure (freezing of gait), remained unresponsive to stimulation; however, improvement in tremor was greater than that achieved with drug therapy alone. These results might be different when using subthalamic stimulation according to preliminary results. 3, 28, [36] [37] [38] [39] [40] Only two patients still perceived motor fluctuations at 12 months after the operation, with a decrease in off time of approximately 30 to 40% at 6 months. However, a slow decline was observed with progressing postoperative time; two more patients began feeling mild fluctuations at 12 months despite adjustments in stimulation parameters. Administration of pergolide up to 1 mg three times per day was introduced at 12 months in these patients with a mild increase in dyskinesia, but this could be responsible for some underestimation of the decrease in efficacy with time after 12 months of follow up.
The improvements in motor and ADL scores cannot be explained by an increase in levodopa dose, because there was no significant change in the mean daily dose of levodopa. A change in the blood-brain barrier may be considered, but this was not studied in our patients. A microthalamotomy effect was ruled out by testing three patients with and without stimulation in the off condition for 12 hours (three patients refused this test because of anxiety concerning return to a severe off condition). Pergolide was not efficient in treating gait ignition failure, which was intermittent in three patients who still perceived slight motor fluctuations after this treatment. This drug cannot be responsible for the general improvement seen in the patients, because no dopamine agonist was introduced before 1 year postoperatively. A major improvement in dyskinesia was seen (the score was reduced to one-third), with no recurrence at 1 year, as already observed with pallidotomy. 10, 17, 24, 27, 31, 42, 51 A trend toward some loss of efficacy was found starting at 1 year, which is compatible with the ongoing progression of the disease, despite readjustments in stimulation parameters.
Our results also show that bilateral contemporaneous pallidal stimulation is safe. Side effects (dysarthria, confusion, and dystonia) were largely controlled by modification of the parameters of stimulation. Flashes at the onset of stimulation, probably due to the proximity of the optic tract, 5,46 were only transient under some level of stimulation. No significant worsening in neuropsychological functions was found after the operation, but marginal improvement in executive functions was seen in some patients, which do not allow any generalization. A mild worsening in dysarthria was seen in two patients. This is in accord with the results of other studies. 44, 45 Acute failure of the stimulator 26 was seen in three patients after passing through security magnets in department stores and in one patient after 1 year due to loss of battery power. The IPG had to be replaced in the latter patient, resulting in the same degree of improvement as before the second operation. Suspected wound infection by one of the wires occurred in one patient, which resolved after 10 days of antibiotic therapy with complete recovery and no complication. We did not encounter ballism; 30, 55 however, dystonia 41 could be elicited by too a high level of stimulation, as well as confusion; however, these symptoms were entirely reversed on changing the parameters of stimulation. Tremor control was satisfactory, 41, 54 better than with drug only, although some degree of tremor could not be entirely prevented by changing the parameters of the stimulation. Changes in levodopa responsiveness 38 were not found, but detailed plasma-controlled studies have not been performed.
Conclusions
Bilateral contemporaneous pallidal stimulation is an efficient alternative for patients who have levodopa-responsive parkinsonism with untreatable motor fluctuations. With a mean improvement in motor and ADL scores of more than 50%, disappearance of any perceptible motor fluctuations after the procedure in all but two patients, and disappearance of more than 80% of the dyskinesia (at the price of keeping approximately the same dose of levodopa as the preoperative regimen), this surgical approach has to be randomly compared with subthalamic bilateral DBS. The mean on scores were not much improved and the levodopa test gave an adequate evaluation of the best postoperative on score. Some degree of akinesia and bradykinesia of rapid hand movements was still perceptible after the operation, as well as gait ignition failure for a few moments each day in two patients; these conditions barely responded to increases in the parameters or changes in the combination of bi-or unipolar modes of stimulation. No significant neuropsychological dysfunction was found after the operation, but two patients showed marginal improvements in some of the parameters of executive functions. One of the major advantages of bilateral pallidal DBS is that medication can be increased with no further increase in dyskinesia, and potential hemorrhagic complications are less likely to be life threatening than in the subthalamic region.
